top of page


We can judge our progress by the courage of our questions and the depth of our answers, our willingness to embrace what is true rather than what feels good.


Workshop, Lecture and Talk

18. Essential modelling & bioinformatics to advance preclinical decision making. Tumour models (Hanson Wade), DoubleTree by Hilton - Tower of London, London (12/2019) PDF (Parts 1 & 3), PDF (Part 2)

17. Good modelling practice for drug discovery & development (12/2018) PDF

16. Using translational modelling to evaluate preclinical tumour models. Tumour models (Hanson Wade), DoubleTree by Hilton Hotel London - Docklands Riverside, London (12/2018) PDF (Part 1), PDF (Part 2)


15. Linking clinical tumour response to preclinical tumour models. Drug Discovery Innovation Programme (World BI), Leonardo Hotel Frankfurt City - South, Frankfurt (11/2018) PDF

14. Translational PK/PD Modelling. UCB Pharma, Slough (11/2018) PDF (Part 1), PDF (Part 2)


13. Novartis Mouse Clinical Trial: Inference. The Open Project, PDF

12. Evaluating Immuno-Oncology Treatment With PK/PD Modelling (3-hour short course). World Preclinical Congress Europe (Cambridge Innovation Institute), Sheraton Lisboa Hotel & Spa, Lisbon (11/2017) PDF

11. Fundamental Guide to Leveraging In Silico Models to Improve Predictability and Understand Applications in Cancer Immunotherapy Drug Discoveries (3-hour pre-conference workshop), the 5th Tumour Models London Summit (Hanson Wade), Hilton London Olympia Hotel, London (12/2016) PDF

10. Exploring mechanism of action of ERK inhibitor, Modeling & Simulation Symposium, AstraZeneca, Mölndal (12/2014)


9. Using multi-scale modeling to support preclinical developments, Cancer Drug Discovery and Preclinical

Development (Active Communications International), Mercure London Kensington Hotel, London (10/2014) PDF


8. Building a multi-scale modeling informed drug discovery and development paradigm – an EGFR inhibitor

story, Modeling & Simulation Symposium, Alderley Park (12/2013) PDF


7. Integrating in vitro with in vivo experiments using computational modeling across different scales -

Ensuring consistency and building confidence, Tumour Models (Hanson Wade), London (01/2013) PDF


6. Sniffers, buzzers, toggles and Cancer, Oncology iMed Training, AstraZeneca, Alderley Park (10/2011)


5. A quantitative model for the translational control of GCN4 in yeast, Dynamics in Systems Biology, Aberdeen



4. A quantitative model for the general mRNA translation in Saccharomyces cerevisiae (2-hour workshop),

BioSysBio Conference, Imperial College London (04/2008)


3. A quantitative model for the translational control of GCN4 in yeast (plenary), Foundations of Systems Biology

in Engineering 2007, Stuttgart (09/2007)


2. Kinetic model: what, why, and how (4-hour training course), Joint Meeting of EC Galar Fungail with EU

CanTrain, Crete (09/2006)


1. SPLASH: Systematic Proteomics Laboratory Analysis and Storage Hub, 1st International Cancer Biomarker

Consortium Meeting, Seoul (08/2005)

bottom of page